Bausch Health Companies Inc. (BHC)
NYSE: BHC · IEX Real-Time Price · USD
7.15
+0.10 (1.42%)
Nov 30, 2023, 12:59 PM EST - Market open
Bausch Health Companies Market Cap
Bausch Health Companies has a market cap or net worth of $2.61 billion as of November 30, 2023. Its market cap has increased by 3.97% in one year.
Market Cap
2.61B
Enterprise Value
24.25B
1-Year Change
3.97%
Ranking
Category
Stock Price
$7.15
Market Cap Chart
Since December 1, 1998, Bausch Health Companies's market cap has increased from $953.20M to $2.61B, an increase of 173.93%. That is a compound annual growth rate of 4.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 29, 2023 | 2.57B | 2.77% |
Nov 28, 2023 | 2.51B | -0.44% |
Nov 27, 2023 | 2.52B | -0.58% |
Nov 24, 2023 | 2.53B | 0.87% |
Nov 22, 2023 | 2.51B | -0.58% |
Nov 21, 2023 | 2.52B | -1.85% |
Nov 20, 2023 | 2.57B | 2.03% |
Nov 17, 2023 | 2.52B | 5.18% |
Nov 16, 2023 | 2.40B | -5.48% |
Nov 15, 2023 | 2.53B | 2.21% |
Nov 14, 2023 | 2.48B | 3.98% |
Nov 13, 2023 | 2.38B | -4.11% |
Nov 10, 2023 | 2.49B | -0.44% |
Nov 9, 2023 | 2.50B | -4.60% |
Nov 8, 2023 | 2.62B | -1.11% |
Nov 7, 2023 | 2.65B | -2.68% |
Nov 6, 2023 | 2.72B | -1.58% |
Nov 3, 2023 | 2.76B | 3.13% |
Nov 2, 2023 | 2.68B | 3.92% |
Nov 1, 2023 | 2.58B | 3.81% |
Oct 31, 2023 | 2.48B | 1.94% |
Oct 30, 2023 | 2.44B | 1.83% |
Oct 27, 2023 | 2.39B | -2.38% |
Oct 26, 2023 | 2.45B | -2.60% |
Oct 25, 2023 | 2.52B | -3.36% |
View and export this data all the way back to 1998.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Amphastar Pharmaceuticals | 2.67B |
ImmunityBio | 2.66B |
Corcept Therapeutics | 2.63B |
Fortrea Holdings | 2.62B |
AMN Healthcare Services | 2.58B |
Biohaven Pharmaceutical Holding Company | 2.57B |
LifeStance Health Group | 2.56B |
Denali Therapeutics | 2.54B |